CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in CRMD — CorMedix Inc.
CIK 884546
SAN FRANCISCO, CA
Position in CRMD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$4,094,139
-$3,010,953 QoQ
Shares Held
602,966
-1.3% QoQ
Ownership
0.769%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRMD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $6,182,986,350 across 288 Biotechnology names. CRMD ranks #143 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,920,871 | $857,745,736 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
804,508 | $621,595,061 | |
| 3 | MRNA |
Moderna, Inc.
|
4,734,356 | $240,505,284 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
673,356 | $222,793,299 | |
| 5 | INSM |
INSMED Inc
|
1,069,390 | $174,866,652 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
1,735,476 | $168,775,041 | |
| 7 | INCY |
Incyte Corp
|
1,729,102 | $162,743,080 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,976,094 | $146,744,740 |
All Filings in CRMD
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,094,139 | 602,966 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $7,105,092 | 610,928 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $6,797,525 | 584,482 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $2,408,005 | 195,455 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,091,478 | 177,188 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $1,412,785 | 174,418 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $1,264,915 | 156,549 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $677,857 | 156,549 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $612,328 | 144,417 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $568,865 | 151,294 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $530,039 | 143,254 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $494,673 | 124,603 | Shares | Sole | 2023-08-10 | |
| 2022-12-31 | $58,860 | 13,948 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $39,472 | 13,948 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $56,070 | 13,948 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $540,821 | 98,690 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $429,014 | 94,289 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $438,443 | 94,289 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $646,822 | 94,289 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $824,954 | 82,578 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $598,716 | 80,581 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $420,640 | 69,758 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $396,597 | 62,952 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $215,012 | 59,892 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||